Creatine Cognition Meta-analysis: What the Evidence Says

Quick Answer

Creatine Cognition Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 systematic review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• These changes contribute to increased sarcopenia risk during and after the menopausal transition, with implications for physical function, frailty, and long-term musculoskeletal health. [Naddafha Siavash (2026); evidence level 1]
• In addition, creatine may exert direct anabolic or anticatabolic effects on muscle cells and influence bone via increased muscle pulling forces or direct cell signaling in osteoblasts. [Naddafha Siavash (2026); evidence level 1]
• The effort to synthesize the available evidence on this important question is greatly appreciated. [Citherlet Tom (2026); evidence level 1]
• In a subsequent letter, Eckert and Pascher showed that including multiple non-independent outcomes from the same participants leads to statistical distortions and increases the risk of false-positive findings. [Citherlet Tom (2026); evidence level 1]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For creatine cognition meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Naddafha Siavash (2026). Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis. DOI: 10.1080/15502783.2026.2668435. PMCID: PMC13182165. PMID: 42141930. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13182165/
• Citherlet Tom (2026). Commentary: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. DOI: 10.3389/fnut.2026.1716285. PMCID: PMC13105953. PMID: 42039906. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13105953/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.